Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Express Scripts
US Army
Baxter
Deloitte
Daiichi Sankyo
US Department of Justice
Federal Trade Commission
Julphar

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 012365

« Back to Dashboard

NDA 012365 describes SOMA COMPOUND, which is a drug marketed by Meda Pharms and is included in two NDAs. Additional details are available on the SOMA COMPOUND profile page.

The generic ingredient in SOMA COMPOUND is aspirin; carisoprodol; codeine phosphate. There are twenty-one drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the aspirin; carisoprodol; codeine phosphate profile page.
Summary for 012365
Tradename:SOMA COMPOUND
Applicant:Meda Pharms
Ingredient:aspirin; carisoprodol
Patents:0
Formulation / Manufacturing:see details

Profile for product number 005

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength325MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Jul 11, 1983TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Moodys
Julphar
AstraZeneca
Cipla
Baxter
Teva
Fish and Richardson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.